1. Clinical & Scientific Overview
Tetanus & Diphtheria Toxoid (Td / TT Wound & Maternal Vaccine) (TIP-MED-000268, Reference Code [12.36]) is classified under
Vaccines, Immunologicals & Emergency Toxicology Antidotes (Ch 12) as a Adsorbed Bacterial Toxoid Vaccine (Active Immunisation against Clostridium tetani & Corynebacterium diphtheriae).
Within the Indian regulatory and compendial framework, it is governed under Schedule H Prescription Drug (To be sold by retail on the prescription of a Registered Medical Practitioner only — Drugs Rules 1945).
Representative Indian Market Examples (Edition 2.7 Ch 12 [12.36], p. 172): Biological E Td / Bett, Serum Institute Td-Vac, Tetvac — Strengths & Dosage Forms: Suspension for Injection: 0.5 mL single-dose ampoule or 5 mL (10-dose) vial (contains >=5 Lf Tetanus toxoid + >=2 Lf Diphtheria toxoid per 0.5 mL).
Suspension for Injection: 0.5 mL single-dose ampoule or 5 mL (10-dose) vial (contains >=5 Lf Tetanus toxoid + >=2 Lf Diphtheria toxoid per 0.5 mL).
3. Mechanism of Action & Pharmacodynamics
Formaldehyde-inactivated tetanus and reduced-dose diphtheria toxoids adsorbed onto aluminium phosphate adjuvant induce protective neutralising IgG antitoxin antibodies (>=0.01 IU/mL).
4. Therapeutic Indications & Evidence-Supported Uses
- Wound-management tetanus prophylaxis
- maternal and neonatal tetanus prevention in pregnancy
- routine adolescent/adult booster immunisation (India's Universal Immunisation Programme replaced standalone TT with Td to sustain adult diphtheria immunity)
🇮🇳 Jurisdiction & Indication Note: Indications and schedules reflect Indian compendial and regulatory records (CDSCO / Indian Pharmacopoeia & NFI / NLEM 2022). Where international reference labels (US FDA DailyMed / NCBI StatPearls) are cited for pharmacokinetic or mechanistic parameters, international approvals do not automatically imply CDSCO approval in India.
5. Educational Dosage Context, Formulations & Administration
Educational Dosing & Regimen Summary: Adult: 0.5 mL deep IM into deltoid. Pregnancy (UIP Schedule): Td-1 at early registration, Td-2 after 4 weeks (or single Td-Booster if 2 doses received in a pregnancy within the last 3 years). Wound Prophylaxis: Give 0.5 mL Td if >10 years since last booster for clean minor wounds, or if >5 years since last booster for tetanus-prone/contaminated wounds (if unimmunised or <3 prior doses with a dirty wound, give BOTH Td 0.5 mL IM AND Human Tetanus Immunoglobulin [TIG] 250–500 IU IM in opposite arms!). • Paediatric: 0.5 mL IM at age 10 years and 16 years per UIP schedule (children <7 years receive Pentavalent/DPT).
Administration & Meal Timing: See Administration & Counselling below. | Standard clinical schedule per indication.
6. Pharmacokinetics, Metabolism & Renal/Hepatic Adjustment
Absorption, distribution, metabolism, and excretion follow class pharmacokinetic profile; verify patient renal/hepatic function.
Renal: No adjustment. • Hepatic: No adjustment.
Renal: No adjustment. • Hepatic: No adjustment.
Renal: No adjustment. • Hepatic: No adjustment.
7. Contraindications, Precautions & High-Risk Warnings
- Contraindications: Anaphylaxis to a previous dose; defer routine booster during acute severe febrile illness (do NOT defer in tetanus-prone wound management). • Precautions: STRICT 'DO NOT FREEZE' COLD-CHAIN RULE (Aluminium-adjuvanted T-series vaccine): Store at 2–8°C; freezing causes irreversible clumping/sedimentation of aluminium adjuvant particles, destroying potency and causing sterile abscesses (perform the 'Shake Test' if freezing is suspected). Frequent unnecessary boosters (<5 years apart) cause severe local Arthus-type hyperimmunisation reactions.
Key Clinical Precautions: Renal: No adjustment. • Hepatic: No adjustment.
8. Adverse Effects Profile
- Mild deltoid soreness, redness, swelling, low-grade fever for 24-48 hours.
- Arthus hypersensitivity reaction (if over-immunised), brachial neuritis, anaphylaxis (extremely rare).
- Monitor for severe hypersensitivity, organ toxicity, or dose-limiting adverse events.
9. Major Drug–Drug, Drug–Food & Drug–Herb Interactions
- May be administered simultaneously with Rabies Vaccine or Tetanus Immunoglobulin (TIG) using separate syringes at different anatomical sites
10. Clinical Monitoring, Patient Counselling & Storage
Clinical & Laboratory Monitoring: Monitor clinical response, baseline renal/hepatic parameters, and relevant serum biomarkers.
Pharmacist Patient Counselling Points:
- Patient Counselling Checklist: Mild arm soreness for 1-2 days responds to paracetamol and cold compress; keep vaccination card safely to avoid unnecessary repeat tetanus shots for minor cuts within 5 years.
- Meal & Clock Timing Instruction: See Administration & Counselling below. (Standard clinical schedule per indication.)
- Missed Dose Protocol: Take as soon as remembered unless close to next scheduled dose; never double the dose.
- Geriatric Dispensing Pearl: Schedule: Schedule H | NLEM 2022: Yes | Compendia: IP 2026 / NFI 7th Ed 2026 / NLEM 2022 / MoHFW UIP Guidelines
Storage, Stability & Dispensing Safeguards: COLD CHAIN MANDATORY (2°C–8°C): Store in a pharmaceutical refrigerator between 2°C and 8°C; DO NOT FREEZE. Protect from light and heat during dispensing.
11. Visual Pharmacology & Mechanism Diagram (svg-v339-01-adme-12-step-journey)
12. Authoritative References, Regulatory Sources & Editorial Disclaimer
Primary Compendial & Guideline Reference: Indian Pharmacist Desk Reference — Professional Edition 2.7 (2026–27) • Ch 12 [12.36] (p. 172)
Official Verification Portals: Indian Pharmacopoeia Commission (IPC) & National Formulary of India (NFI) • Central Drugs Standard Control Organization (CDSCO) • Ministry of Health & Family Welfare — NLEM 2022 • NCBI Bookshelf / StatPearls Pharmacology Reference • DailyMed (US FDA Official Prescribing Reference)
Last Medically & Pharmaceutically Reviewed: 2026-11-10 • Verification Status: HANDBOOK_SOURCE_CONTENT
Educational & Clinical Disclaimer: This reference profile is published solely for pharmacy education, academic study, and professional clinical reference. It does not substitute for patient-specific clinical judgement, qualified specialist oncology/medical supervision, or official CDSCO/IP prescribing information. Never self-medicate with prescription, Schedule H/H1/X, NDPS, or oncology medicines.
13. Related Reference Monographs, Educational Guides & Visual Concept
💊 Related Pharmacological / Category Profiles
- [12.33] Pralidoxime Chloride / Iodide (2-PAM Cholinesterase Reactivator) — Cholinesterase Reactivator Oxime Antidote (Organophosphate Antido
- [12.34] Polyvalent Anti-Snake Venom (Indian 'Big Four' Lyophilised ASV) — Equine Hyperimmune F(ab')2 Immunoglobulin Antivenom against India
- [12.35] Rabies Vaccine (ID/IM Cell-Culture) & Rabies Immunoglobulin (RIG) — Inactivated Cell-Culture Rabies Vaccine (Active Immunisation) & P
- [12.37] Calcium Gluconate (10% IV Cardioprotective & Hypocalcaemia Injection) — Parenteral Calcium Salt (Myocardial Membrane Stabiliser & Electro
